Clover Health Investments, Corp. (CLOV)
Summary
Clover Health Is A 'Buy' Because Of Its AI
Clover Health Investments, Corp. leverages its AI-powered Clover Assistant to drive lower claims costs and improve member profitability. Baseline and bullish DCF valuations yield fair values of $5.02 and $14.10 per share, respectively, versus the current $4.15 price. Key upside drivers include rapid membership growth, AI-enabled cost savings, and a potential $120M Medicare Advantage bonus tied to a 4.5-star CMS rating.
Clover Health Investments: Real Turnaround, But Already Priced In
Clover Health Investments (CLOV) is rated Hold, with operational execution but a cautious outlook due to valuation and litigation risks. CLOV's Medicare Advantage membership grew 48% YoY, revenue and GAAP net income improved, but profitability per member lags FY2024 levels. FY2026 guidance implies negative H2 results; $120M in quality bonus revenue is at risk pending CMS litigation outcome.
Clover Health Is Proving Its Profit Model
Clover Health (CLOV) has delivered strong growth, profitability, and improved guidance, supporting my continued Strong Buy rating. CLOV's Medicare Advantage membership grew 48% YoY, with revenue up 56% and gross profit up 54%, driven by cohort maturation and the Clover Assistant platform. Valuation remains attractive at a 78% discount to sector median EV/sales, with upside potential if per-member profitability and SaaS revenue trends persist.
Clover Health Investments, Corp. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Curtis Ellergodt Rothschild Investment LLC | 602 | $1,383.5 | $2,510.34 | $1,126.84 | 81.45% |
| JD Jim Dushek HARBOUR INVESTMENTS Inc. | 50 | $46.47 | $219.5 | $173.03 | 372.35% |
| NA Nizar Araji National Bank Of Canada /FI/ | 37,173 | $103,692.87 | $176,943.48 | $73,250.61 | 70.64% |
| OD Olivier Doublet Caisse Des Depots Et Consignations | 121,655 | $637,472.01 | $507,301.35 | -$130,170.66 | -20.42% |
| BG Bart Gancher Intech Investment Management LLC | 99,936 | $261,076.68 | $475,695.36 | $214,618.68 | 82.21% |
Clover Health Investments, Corp. (CLOV) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Clover Health Investments, Corp. ever had a stock split?
Clover Health Investments, Corp. Profile
| Health Care Providers & Services Industry | Healthcare Sector | Andrew Toy CEO | NASDAQ (NGS) Exchange | 18914F103 CUSIP |
| US Country | 724 Employees | 23 Aug 2021 Last Dividend | - Last Split | - IPO Date |
Overview
Clover Health Investments, Corp., headquartered in Franklin, Tennessee, is a healthcare company that specializes in providing Medicare Advantage plans across the United States. The company operates two main segments: Insurance and Non-Insurance, targeting to enhance the healthcare experience for Medicare beneficiaries through tech-driven solutions and data analysis. By focusing on predictive healthcare and proactive management of chronic diseases, Clover Health aims to improve patient outcomes while controlling costs.
Products and Services
- Medicare Advantage Plans:
As its core offering, Clover Health Investments, Corp. delivers Medicare Advantage plans designed to meet the diverse needs of Medicare beneficiaries. These plans are structured to provide more benefits than traditional Medicare, including prescription drug coverage, preventive care, and access to a broad network of healthcare professionals.
- Clover Assistant:
This innovative, cloud-based software platform is a key differentiator for Clover Health. The Clover Assistant facilitates data-driven and personalized healthcare by enabling physicians to detect, identify, and manage chronic conditions more effectively and earlier in their progression. By providing access to comprehensive, real-time health data and insights about their patients, Clover Assistant empowers healthcare providers to make informed decisions that enhance patient care and outcomes.
